3
Announcements
Trials
Browse
Landscape
Status
Completed
12
Terminated
7
Active not recruiting
6
Recruiting
4
Withdrawn
2
Unknown
2
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
5
Thoracic
2
Gastrointestinal
2
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
CNS
1
Breast
1
Conditions
Hematopoietic and Lymphatic System Neoplasm
5
Carcinoma, Non-Small-Cell Lung
3
Solid Tumor
2
Retinoblastoma
2
Mesothelioma
2
Advanced Solid Tumor
2
von Willebrand Disease, Type 3
1
beta-Thalassemia
1
Xanthomatosis, Cerebrotendinous
1
X-Linked Combined Immunodeficiency Diseases
1
Wolman Disease
1
Waardenburg syndrome type 2A
1
Waardenburg syndrome type 2
1
Waardenburg Syndrome
1
VLCAD deficiency
1
Usher syndrome, type 1F
1
Usher syndrome, type 1C
1
Usher syndrome, type 1B
1
Tyrosinemias
1
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Triple Negative Breast Neoplasms
1
Trifunctional Protein Deficiency With Myopathy And Neuropathy
1
Thyroid Dyshormonogenesis 6
1
Thyroid Dyshormonogenesis 5
1
Thyroid Dyshormonogenesis 3
1
Thyroid Dyshormonogenesis 2A
1
Thyroid Dyshormonogenesis 1
1
Thymus Neoplasms
1
Thymoma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Squamous Cell Carcinoma of Head and Neck
×
Other solid neoplasm
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled